The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration adverse event reporting system (FAERS)

CONCLUSIONS: Using the Bradford Hill criteria however and taking into consideration confounders, no causal link between GLP-1 RAs and suicidality exists.PMID:38087976 | DOI:10.1080/14740338.2023.2295397
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Authors: Source Type: research